GlassScriptPhysician profile
Alan Zajarias
NPI 1679696579
$202,984.87
in general payments reported to CMS, 2019-2025
24 companies · $63K in 2025
The $63K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $28K · 2021: $14K · 2022: $21K · 2023: $22K · 2024: $22K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Travel and Lodging: $32K · Consulting Fee: $27K · Food and Beverage: $8,817 · Honoraria: $2,750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,531.25 |
| Travel and Lodging | $31,597.73 |
| Consulting Fee | $27,040.80 |
| Food and Beverage | $8,817.22 |
| Honoraria | $2,750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $71,042.59 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $58,235.40 | 2021-2025 | Apollotm, Onyx Frontier, Corevalve Evolut R |
| Boston Scientific Corporation | $23,715.82 | 2019-2025 | Versacross Access Solution, Filterwire Ez, Rotapro |
| Abiomed | $19,189.15 | 2019-2025 | Impella |
| Admedus Corporation | $14,000.00 | 2019-2020 | |
| Abbott Laboratories | $5,972.94 | 2019-2025 | Mitraclip, Triclip, Portico |
| Artivion, INC. | $2,200.00 | 2021 | |
| Bard Peripheral Vascular, INC. | $2,039.58 | 2019-2020 | |
| Philips North America LLC | $1,477.83 | 2019-2025 | Intracardiac Undivided, Igt Devices Undivided |
| Ge Healthcare | $1,133.12 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $800.00 | 2020 | |
| Penumbra, INC. | $549.81 | 2021-2023 | Indigo System |
| Jenavalve Technology, INC. | $440.16 | 2023-2024 | Jenavalve Pericardial Tavr System |
| Biotronik INC. | $427.91 | 2021-2025 | Orsiro Mission |
| Teleflex LLC | $409.78 | 2021-2025 | Guideliner, Pantera Leo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $380.06 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $284.91 | 2022 | |
| Cardiovascular Systems INC. | $261.26 | 2019-2021 | |
| Heartflow, INC. | $143.02 | 2022 | |
| Ancora Heart, INC. | $119.34 | 2024 | Accucinch |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.86 | 2019-2023 | Lifevest |
| Shockwave Medical, INC | $35.87 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Merck Sharp & Dohme LLC | $12.07 | 2022 | |
| Z-Medica, LLC | $8.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Zajarias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.